Phase 1 N=28 Terbinafine HCl 250 mg Tablet Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration - Terbinafine in Plasma — 840.2; 873.2 ng/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=50 Trandolapril 4 mg Tablet Under Non-Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 5.2604; 5.4938 ng/mL
Phase 1 N=24 Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 117.313; 116.452 ng/mL
Phase 1 N=60 Oxcarbazepine 600 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration - Oxcarbazepine in Plasma — 1630.3; 1620.2 ng/mL
Phase 1 N=40 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting
Healthy
Primary: Cmax (Maximum Observed Concentration) - Glipizide in Plasma — 377.949; 381.282 ng/mL
Phase 1 N=32 15 mg Mirtazapine Orally Disintegrating Tablets, Fasting
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 32975.95; 33122.52 pg/mL
Phase 1 N=41 Zaleplon 10mg Capsules Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 27.080; 27.487 ng/mL
Phase 1 N=28 Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 80.334; 71.483 ng/mL
Phase 1 N=28 Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 57.26; 56.66 ng/mL
Phase 1 N=32 Metformin ER 750 mg Tablets, Fasting
Healthy
Primary: Cmax (Maximum Observed Concentration of Drug Substance in Plasma) — 875.86; 886.39 ng/mL
Phase 1 N=46 Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors
Cancer · Refractory Solid Tumor
Primary: Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RPIID) of Cetuximab in Combination With Irinotecan — 250; 250; 16; 20 mg/m2
Phase 1 N=32 Bioequivalence Study of 200 mg Lamotrigine Tablet Under Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 2912.04; 2802.93 ng/mL
Phase 1 N=32 Glimepiride 4 mg Tablets Under Non-Fasting Conditions
Healthy
Primary: Cmax - Maximum Observed Concentration — 267.629; 266.706 ng/mL
Phase 1 N=36 Famciclovir 500 mg Tablets Under Fasting Conditions
Healthy
Primary: Cmax = Maximum Observed Concentration. — 3265.647; 3521.118 ng/mL
Phase 1 N=48 Desmopressin Acetate 0.2 mg Tablets, Fasting
Healthy
Primary: Cmax - Maximum Observed Concentration — 78.102; 82.888 pg/mL